The Africa Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.

Press releases published on October 12, 2026

Oct. 12, 2026

His Royal Majesty King Tikoe Tefo Meshack Lekitlane Honored in Zimbabwe with the Global Voice of Civility Award

Indeterminate EIN Presswire

Oct. 12, 2026

NexLife Announces October 2026 GLP-1 Price Index on Online Prices of Compounded Tirzepatide and Semaglutide

Indeterminate GlobeNewswire

Oct. 12, 2026

Organogenesis Announces Publication of Peer-Reviewed PREPARE Trial Results Demonstrating Clinical Benefit of PuraPly®AM for Hard-to-Heal Diabetic Foot Ulcers

Indeterminate GlobeNewswire

Oct. 12, 2026

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026

Indeterminate GlobeNewswire

Oct. 12, 2026

Apnimed to Present Five Abstracts, Including Two Late-Breakers at CHEST 2026

Indeterminate GlobeNewswire

Oct. 12, 2026

PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026

Indeterminate GlobeNewswire

Oct. 12, 2026

Oncolytics Biotech® Secures Patent Protection to Late 2040s and Provides Intellectual Property Portfolio Update

Indeterminate GlobeNewswire

Oct. 12, 2026

泛非商业银行（Ecobank）集团与CIPS达成合作，加强中非金融通道

Indeterminate GlobeNewswire

Oct. 12, 2026

Ecobank Group and CIPS Partner to strengthen China-Africa financial corridor

Indeterminate GlobeNewswire

Oct. 12, 2026

Le Groupe Ecobank et CIPS s’associent pour renforcer le corridor financier entre la Chine et l’Afrique

Indeterminate GlobeNewswire

Oct. 12, 2026

Palisade Bio Presents New Clinical, Pharmacokinetic, Pharmacodynamic and Mechanistic Data Strengthening the Phase 2 Rationale for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at ACG 2026

Indeterminate GlobeNewswire

Oct. 12, 2026

Ardelyx Presents Real-World Data at ACG 2026 Showing Reduced Healthcare Resource Utilization Following IBSRELA® Initiation in Adults with IBS-C

Indeterminate GlobeNewswire

Oct. 12, 2026

Odyssey Therapeutics to Present Design of Phase 2a Study Evaluating OD-001 in Combination with Vedolizumab at ACG 2026

Indeterminate GlobeNewswire

Oct. 12, 2026

Clearmind: Charging Robotics Launches Next-Generation Automated EV-Charging Technology for Robotaxis and Autonomous Fleets

Indeterminate GlobeNewswire

Oct. 12, 2026

CervoMed Presents Initial Results of Phase 2a Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Showing Positive Effects on a Key Neurodegeneration Biomarker in Late-Breaking Oral Session at ISFTD 2026

Indeterminate GlobeNewswire

Oct. 12, 2026

NervGen Announces First Participant Dosed in RESTORE, a Phase 3 Registrational Study Evaluating NVG-291 in Chronic Spinal Cord Injury

Indeterminate GlobeNewswire

Oct. 12, 2026

Greenland Mines Welcomes EU Selection of Neo Performance Materials’ Silmet 2.0 as Strategic Project; Highlights Sarfartoq’s Potential Role in Secure Transatlantic Rare Earth Supply

Indeterminate GlobeNewswire

Oct. 12, 2026

Fate Therapeutics Appoints Jamie Harrell as Senior Vice President, Market Development & Commercial Operations to Lead the Commercialization of CAR T-cell Therapies

Indeterminate GlobeNewswire

Oct. 12, 2026

Beacon Therapeutics Presents Data from Pivotal VISTA Trial of Laru-zova at AAO 2026

Indeterminate GlobeNewswire

Oct. 12, 2026

Zenas BioPharma Announces the Presentation of New Obexelimab Data in IgG4-Related Disease at the 6th International Symposium on IgG4-Related Disease

Indeterminate GlobeNewswire